FIELD: medicine.
SUBSTANCE: invention relates to restorative medicine, in particular to physical therapy, and concerns the use of a dietary supplement that improves the coordination of the musculoskeletal system of a person with 2nd degree obesity. Biologically, the dietary supplement contains oxy-ethylammonium methylphenoxyacetate, beta-carotene, alpha-tocopherol, garlic and lactose.
EFFECT: invention provides an improvement in the coordination of the musculoskeletal system of a person with 2nd degree obesity.
1 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| TOOL IMPROVING THE COORDINATION OF THE MUSCULOSKELETAL SYSTEM OF A PERSON WITH 1ST DEGREE OBESITY | 2021 |
|
RU2761618C1 |
| MEANS THAT IMPROVES THE COORDINATION OF THE MUSCULOSKELETAL SYSTEM OF A PERSON WITH 2 DEGREE OBESITY | 2021 |
|
RU2775179C1 |
| MEANS TO IMPROVE THE COORDINATION OF THE MUSCULOSKELETAL SYSTEM OF A PERSON WITH 1 DEGREE OBESITY | 2021 |
|
RU2775178C1 |
| AGENT INCREASING FERRITIN CONCENTRATION IN HUMAN BLOOD SERUM | 2022 |
|
RU2794847C1 |
| LIQUID PHARMACEUTICAL COMPOSITION OXYETHYLAMMONIUM METHYLPHENOXYACETATE | 2021 |
|
RU2783660C2 |
| METHOD OF REHABILITATING TREATMENT OF PATIENTS WITH ISCHEMIC HEART DISEASE IN SANATORIUM AND OUTPATIENT CONDITIONS | 2010 |
|
RU2464006C2 |
| METHOD FOR IMPROVING HUMAN PRODUCTIVITY | 2014 |
|
RU2601102C2 |
| METHOD OF COMPLEX REHABILITATION OF PATIENTS WHO HAVE HAD COVID-19 WITH LUNG DAMAGE AT THE SECOND STAGE OF MEDICAL REHABILITATION | 2023 |
|
RU2800253C1 |
| ADAPTOGENIC, IMMUNOMODULATING AND ANTI-VIRAL PHARMACEUTICAL COMPOSITION OF OXYETHYLAMMONIUM METHYLPHENOXYACETATE | 2023 |
|
RU2806534C1 |
| APPARATUS FOR TRAINING PAIR BALANCING | 2020 |
|
RU2754346C1 |
